Home / Inspections / 1099381

FDA Inspection 1099381 — Padagis Israel Pharmaceuticals Ltd.

Padagis Israel Pharmaceuticals Ltd. — FEI 3001904238

The FDA completed an inspection of Padagis Israel Pharmaceuticals Ltd. on June 13, 2019 in Yerucham. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 13, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Yerucham (Israel)

Additional Details

Bioanalytical BA/BE

Facility

Other inspections at this facility

  • 1220679 (NAI Wed Sep 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1191880 (NAI Thu Oct 27 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1065389 (NAI Thu Jul 19 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 910286 (VAI Thu Jan 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 837639 (VAI Mon Aug 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources